Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Cooper

Showing results (301-310 of 399) with videos related to

Pageof 40
Sort By:
Diabetologia|October 29, 2015
Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathyJay C Jha, Vicki Thallas-Bonke, Claudine Banal, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 23, 2017
Resveratrol Inhibits Growth of Experimental Abdominal Aortic Aneurysm Associated With Upregulation of Angiotensin-Converting Enzyme 2Corey S Moran, Erik Biros, Smriti M Krishna, et al.
Physiological Reports|November 5, 2014
Nox-4 deletion reduces oxidative stress and injury by PKC-α-associated mechanisms in diabetic nephropathyVicki Thallas-Bonke, Jay C Jha, Stephen P Gray, et al.
Science Advances|May 29, 2026
EZH2 inhibition via GSK-126 mitigates EndMT and atherosclerosis in diabetes: A translational epigenetic approachMisbah Aziz, Karly C Sourris, Jairo A Pinzon-Cortes, et al.
Diabetes|June 16, 2012
Alagebrium reduces glomerular fibrogenesis and inflammation beyond preventing RAGE activation in diabetic apolipoprotein E knockout miceAnna M D Watson, Stephen P Gray, Li Jiaze, et al.
Circulation Research|July 31, 2010
Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouseMerlin C Thomas, Raelene J Pickering, Despina Tsorotes, et al.
Diabetes|October 29, 2002
Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathyJosephine M Forbes, Mark E Cooper, Vicki Thallas, et al.
Hypertension (Dallas, Tex. : 1979)|December 21, 2018
Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes MellitusToshiaki Ohkuma, Min Jun, Anthony Rodgers, et al.
Diabetes|March 5, 2009
c-Jun NH2-terminal kinase activity in subcutaneous adipose tissue but not nuclear factor-kappaB activity in peripheral blood mononuclear cells is an independent determinant of insulin resistance in healthy individualsKarly C Sourris, Jasmine G Lyons, Maximilian P J de Courten, et al.
BMJ Open Diabetes Research & Care|December 3, 2014
Retinopathy and clinical outcomes in patients with type 2 diabetes mellitus, chronic kidney disease, and anemiaNatalie A Bello, Marc A Pfeffer, Hicham Skali, et al.
Pageof 40

Showing results (301-310 of 399) with videos related to

Sort By:
Pageof 40
Diabetologia|October 29, 2015
Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathyJay C Jha, Vicki Thallas-Bonke, Claudine Banal, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 23, 2017
Resveratrol Inhibits Growth of Experimental Abdominal Aortic Aneurysm Associated With Upregulation of Angiotensin-Converting Enzyme 2Corey S Moran, Erik Biros, Smriti M Krishna, et al.
Physiological Reports|November 5, 2014
Nox-4 deletion reduces oxidative stress and injury by PKC-α-associated mechanisms in diabetic nephropathyVicki Thallas-Bonke, Jay C Jha, Stephen P Gray, et al.
Science Advances|May 29, 2026
EZH2 inhibition via GSK-126 mitigates EndMT and atherosclerosis in diabetes: A translational epigenetic approachMisbah Aziz, Karly C Sourris, Jairo A Pinzon-Cortes, et al.
Diabetes|June 16, 2012
Alagebrium reduces glomerular fibrogenesis and inflammation beyond preventing RAGE activation in diabetic apolipoprotein E knockout miceAnna M D Watson, Stephen P Gray, Li Jiaze, et al.
Circulation Research|July 31, 2010
Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouseMerlin C Thomas, Raelene J Pickering, Despina Tsorotes, et al.
Diabetes|October 29, 2002
Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathyJosephine M Forbes, Mark E Cooper, Vicki Thallas, et al.
Hypertension (Dallas, Tex. : 1979)|December 21, 2018
Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes MellitusToshiaki Ohkuma, Min Jun, Anthony Rodgers, et al.
Diabetes|March 5, 2009
c-Jun NH2-terminal kinase activity in subcutaneous adipose tissue but not nuclear factor-kappaB activity in peripheral blood mononuclear cells is an independent determinant of insulin resistance in healthy individualsKarly C Sourris, Jasmine G Lyons, Maximilian P J de Courten, et al.
BMJ Open Diabetes Research & Care|December 3, 2014
Retinopathy and clinical outcomes in patients with type 2 diabetes mellitus, chronic kidney disease, and anemiaNatalie A Bello, Marc A Pfeffer, Hicham Skali, et al.
Pageof 40